Evaluation of the relationship between thyroid cancer and the concurrent detection of thyroid nodules on the background of primary hyperparathyroidism

Alisha Poppen

doi:10.33178/SMJ.2019.1.5

Authors

Alisha Poppen

DOI:

https://doi.org/10.33178/SMJ.2019.1.5

Keywords:

hyperparathyroidism, thyroid cancer, thyroid nodules, PHPT, papillary thyroid cancer

Abstract

Introduction: Primary Hyperparathyroidism (PHPT) is commonly caused by a benign parathyroid adenoma that results in overactivity of the gland and subsequent hypercalcemia due to elevated parathyroid hormone (PTH). This endocrine pathology is associated with thyroid cancer, specifically Papillary Thyroid Cancer (PTC). However, the explanation for their synchronous presentation is unknown. Moreover, it causes diagnostic and treatment challenges that impact patient outcomes.

Aims and Objectives: To critically analyze published research to address the relationship between PHPT and thyroid cancer, the role of ultrasound imaging in detecting sinister thyroid nodules in PHPT patients and the features of PHPT that predispose the risk of thyroid malignancy.

Study Design: Literature Review

Methodology: Electronic database searches of PubMed and CINAHL Plus through EBSCOhost were conducted using the keywords "primary hyperparathyroidism", "thyroid nodules" and "thyroid cancer". Following application of filters and removal of duplicates, 627 relevant results remained. Articles were screened for eligibility based on predetermined selection criteria. Following a review of titles and abstracts, 10 peer-reviewed articles were chosen for further analysis. The studies included were critically appraised using the EBL Critical Appraisal Checklist.

Results: 10 articles were examined, 2 were prospective cohort studies and 8 were retrospective cohort studies. All studies involved exhaustive medical chart reviews of patients with PHPT, to investigate the concomitance of thyroid malignancy. Six studies established cervical ultrasound as the optimal method of recognition and preoperative localization of thyroid and parathyroid lesions. Overall, the incidence of thyroid cancer among PHPT patients ranged between 2.9% to 32.9%. Four studies established age, gender and PTH levels as risk factors.

Conclusion: The existing literature is consistent with previous studies and purports that individuals with a background fo PHPT are at an increased risk of thyroid cancer. Furthermore the highest likelihood of identifying thyroid cancer is through preoperative localization of parathyroid adenomas by cervical ultrasound, in female patients over the age of 50.

Key Findings: Further research is needed to understand the underlying pathogenesis and genetic mechanisms that encompass the relationship between PHPT and thyroid cancer.

References

Center NP. Parathyroid Glands, High Calcium, and Hyperparathyroidism [updated Jan 15 2020. Available from: https://www.parathyroid.com/.

Heath D. Primary hyperparathyroidism Clinical presentation and factors influencing clinical management. Endocrinol Metab Clin North Am. 1989;18:631-46.

Wilson SD DK, Wang TS Primary hyperparathyroidism with a history of head and neck irradiation: The consequences of associated thyroid tumors. Surgery. 2011;150:869-77.

Wright M-C, Jensen K, Mohamed H, Drake C, Mohsin K, Monlezun D, et al. Concomitant thyroid disease and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Gland surgery. 2017;6 (4):368-74.

Miccoli P, Minuto MN, Galleri D, D'Agostino J, Basolo F, Antonangeli L, et al. Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. ANZ journal of surgery. 2006;76(3):123-6.

Bradly DP, Reddy V, Prinz RA, Gattuso P. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery. 2009;146(6):1099-104.

Yazici P, Mihmanli M, Bozdag E, Aygun N, Uludag M. Incidental Finding of Papillary Thyroid Carcinoma in the Patients with Primary Hyperparathyroidism. Eurasian J Med. 2015;47(3):194-8.

Wilhelm SM WT, Ruan DT et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151 (10):959-68.

Adler JT, Chen H, Schaefer S, Sippel RS, Adler JT, Chen H, et al. Does routine use of ultrasound result in additional thyroid procedures in

patients with primary hyperparathyroidism? Journal of the American College of Surgeons. 2010;211(4):536-9.

Barbaros U, Erbil Y, Salmashoglu A, Issever H, Aral F, Tunaci M, et al. The characteristics of concomitant thyroid nodules cause false-positive ultrasonography results in primary hyperparathyroidism. American Journal of Otolaryngology. 2009;30(4):239-43.

Cetin K, Sikar HE, Temizkan S, Ofluoglu CB, Ozderya A, Aydin K, et al. Does Primary Hyperparathyroidism Have an Association with Thyroid Papillary Cancer? A Retrospective Cohort Study. World J Surg. 2019;43(5):1243-8.

Cuhaci N, Ozdemir D, Polat B, Arpaci D, Yildirim N, Yazgan AK, et al. Concomitant thyroid lesions in patients with primary hyperparathyroidism. Asian J Surg. 2017;40 (5):338-44.

Preda C, Branisteanu D, Armasu I, Danila R, Velicescu C, Ciobanu D, et al. Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics. BMC Surg. 2019;19(1):94.

Scerrino G, Attard M, Lo Piccolo C, Attard A, Melfa GI, Raspanti C, et al. The coexistence of primary hyperparathyroidism and thyroid

nodules: should the preoperative work-up of the parathyroid and the thyroid diseases be specifically adjusted? G Chir. 2016;37(3):123-9.

Shen J, Wu Q, Wang Y. The role of ultrasound in the diagnosis of the coexistence of primary hyperparathyroidism and non-medullary thyroid carcinoma. BMC Med Imaging. 2019;19 (1):7.

Vargas-Ortega G, Balcázar-Hernández L, González-Virla B, Ramírez-Rentería C, Nieto-Guzmán O, Garrido-Mendoza AP, et al. Symptomatic Primary Hyperparathyroidism as a Risk Factor for Differentiated Thyroid Cancer. Journal of Thyroid Research. 2018:1-6.

Xue Y, Ye ZQ, Zhou HW, Shi BM, Yi XH, Zhang KQ. Serum Calcium and Risk of Nonmedullary Thyroid Cancer in Patients with Primary

Hyperparathyroidism. Med Sci Monit. 2016;22:4482-9.